A case of lymphoid interstitial pneumonia in a 3-month-old boy not associated with HIV infection: Immunohistochemistry of lung biopsy specimens and serum transforming growth factor-β1 assay

Pathology International

Volumn 47, Issue 10, 1997, Pages 698-702

  Koga, Mayumi ^a   Umemoto, Yumi ^a   Nishikawa, Miki ^a   Nakashima, Kanae ^a   Ishihara, Tokuhiro ^a   Furukawa, Susumu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HLA DR; Immunohistochemistry; Lymphoid interstitial pneumonia; Transforming growth factor 1

Indexed keywords

HLA DR ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; INFANT; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LYMPH FOLLICLE; LYMPHOID CELL; MALE; PLASMA CELL; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0030729648     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04444.x     Document Type: Article

References (10)

1. Carrington CB, Liebow AA. Lymphocytic interstitial pneumonia (abstract). Am. J. Pathol. 1966; 48: 36a.
2. Brenner TJ, Dahl KE, Olson B, Miller G, Andiman WA. Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children. Lancet 1991; 337: 1001-1005.
3. Evlogias NE, Leonidas JC, Rooney J, Valderama E. Severe cystic pulmonary disease associated with chronic Pneumicystis carinii infection in a child with AIDS. Pediatr. Radiol. 1994; 24: 606-608.
4. Antoniades HN, Bravo MA, Avila RE et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J. Clin. Invest. 1990; 86: 1055-1064.
5. Martinet Y, Rom WN, Grotendorst GR, Martin GR, Crystal RG. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 1987; 317: 202-209.
6. Hoyt DG, Lazo JS. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-β precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 1988; 246: 765-771.
7. Khalil N, O'Connor RN, Unruh HW et al. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 1991; 5: 155-162.
8. Haslam PL, Thompson B, Mohammed I et al. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin. Exp. Immunol. 1979; 37: 381-390.
9. Haslam PL, Allan F, Watling AF, Barrett C, Morris L, Turner-Warwick M. Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis). Clin. Exp. Immunol. 1982; 49: 59-66.
10. Campbell DA, Poulter LW, Janossy G, Du Bois RM. Immunohistochemical analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax 1985; 40: 405-411.